Product Code: ETC191562 | Publication Date: May 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
The Vietnam Intravenous Iron Drugs Market is witnessing growth, propelled by the rising prevalence of iron deficiency disorders and anemia. Healthcare facilities and medical professionals are increasingly adopting intravenous iron drugs for efficient and rapid treatment. The market is characterized by the presence of pharmaceutical companies offering a diverse range of intravenous iron formulations. Factors such as the aging population, changing dietary habits, and advancements in healthcare infrastructure contribute to the market`s expansion.
The Vietnam Intravenous Iron Drugs Market is witnessing growth due to rising cases of iron deficiency anemia and the increasing awareness of healthcare. Intravenous iron drugs are used in the treatment of severe iron deficiencies and chronic diseases. As healthcare infrastructure and awareness improve, the demand for such drugs increases.
The Vietnam Intravenous Iron Drugs market is confronted with challenges related to healthcare infrastructure and patient awareness. While there is a growing need for intravenous iron drugs in the country, the healthcare infrastructure may not be adequately equipped to provide these treatments to patients, particularly in rural areas. Moreover, patient awareness and understanding of the benefits of intravenous iron drugs may be limited, leading to hesitancy among both healthcare providers and patients. Access to these drugs and affordability can also be issues, as they are not always covered by insurance, making them expensive for patients.
The Intravenous Iron Drugs market in Vietnam has experienced disruptions due to the pandemic, with a shift in healthcare priorities towards managing and treating COVID-19 cases. Non-urgent medical treatments and elective procedures have been deferred, affecting the demand for intravenous iron drugs. As the healthcare system adapts and recovers, the market is likely to witness a resurgence, especially with a renewed focus on addressing chronic diseases and healthcare infrastructure development.
In the Vietnam Intravenous Iron Drugs market, industry leaders such as Vifor Pharma Ltd., Pharmacosmos A/S, and AMAG Pharmaceuticals, Inc. play a crucial role. These companies are at the forefront of addressing iron deficiency through innovative intravenous iron drug formulations. Their research and development initiatives contribute significantly to improving healthcare outcomes in Vietnam.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Intravenous Iron Drugs Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Intravenous Iron Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Intravenous Iron Drugs Market - Industry Life Cycle |
3.4 Vietnam Intravenous Iron Drugs Market - Porter's Five Forces |
3.5 Vietnam Intravenous Iron Drugs Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Vietnam Intravenous Iron Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Vietnam Intravenous Iron Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Intravenous Iron Drugs Market Trends |
6 Vietnam Intravenous Iron Drugs Market, By Types |
6.1 Vietnam Intravenous Iron Drugs Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Iron Dextran, 2021-2031F |
6.1.4 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Iron Sucrose, 2021-2031F |
6.1.5 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Ferric Carboxymaltose, 2021-2031F |
6.1.6 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Vietnam Intravenous Iron Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Chronic Kidney Disease, 2021-2031F |
6.2.3 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Inflammatory Bowel Disease, 2021-2031F |
6.2.4 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Cancer, 2021-2031F |
6.2.5 Vietnam Intravenous Iron Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Vietnam Intravenous Iron Drugs Market Import-Export Trade Statistics |
7.1 Vietnam Intravenous Iron Drugs Market Export to Major Countries |
7.2 Vietnam Intravenous Iron Drugs Market Imports from Major Countries |
8 Vietnam Intravenous Iron Drugs Market Key Performance Indicators |
9 Vietnam Intravenous Iron Drugs Market - Opportunity Assessment |
9.1 Vietnam Intravenous Iron Drugs Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Vietnam Intravenous Iron Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Vietnam Intravenous Iron Drugs Market - Competitive Landscape |
10.1 Vietnam Intravenous Iron Drugs Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Intravenous Iron Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |